C1QL1

gene
On this page

Also known as CRFC1QRFC1QTNF14CTRP14

Summary

C1QL1 (complement C1q like 1, HGNC:24182) is a protein-coding gene on chromosome 17q21.31, encoding C1q-related factor (O75973). May regulate the number of excitatory synapses that are formed on hippocampus neurons.

Predicted to enable signaling receptor binding activity. Predicted to be involved in locomotory behavior. Predicted to act upstream of or within maintenance of synapse structure; motor learning; and neuron remodeling. Predicted to be located in several cellular components, including climbing fiber; extracellular region; and presynapse. Predicted to be part of collagen trimer. Predicted to be active in cerebellar climbing fiber to Purkinje cell synapse and synaptic cleft.

Source: NCBI Gene 10882 — RefSeq curated summary.

At a glance

  • GWAS associations: 9
  • Clinical variants (ClinVar): 44 total — 1 pathogenic
  • MANE Select transcript: NM_006688

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24182
Approved symbolC1QL1
Namecomplement C1q like 1
Location17q21.31
Locus typegene with protein product
StatusApproved
AliasesCRF, C1QRF, C1QTNF14, CTRP14
Ensembl geneENSG00000131094
Ensembl biotypeprotein_coding
OMIM611586
Entrez10882

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000253407, ENST00000718438

RefSeq mRNA: 1 — MANE Select: NM_006688 NM_006688

CCDS: CCDS11492

Canonical transcript exons

ENST00000253407 — 2 exons

ExonStartEnd
ENSE000008542964495969344960367
ENSE000008542974496745244968303

Expression profiles

Bgee: expression breadth ubiquitous, 186 present calls, max score 93.70.

FANTOM5 (CAGE): breadth broad, TPM avg 3.6959 / max 287.6817, expressed in 693 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1664843.0294639
1664830.3753187
1664850.2912153

Top tissues by expression

276 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
paraflocculusUBERON:000535193.70gold quality
middle frontal gyrusUBERON:000270292.66silver quality
Brodmann (1909) area 10UBERON:001354191.73silver quality
amygdalaUBERON:000187689.63gold quality
cingulate cortexUBERON:000302788.80gold quality
anterior cingulate cortexUBERON:000983588.80gold quality
endometrium epitheliumUBERON:000481188.73gold quality
hypothalamusUBERON:000189887.98gold quality
C1 segment of cervical spinal cordUBERON:000646987.97gold quality
spinal cordUBERON:000224086.61gold quality
right frontal lobeUBERON:000281084.30gold quality
type B pancreatic cellCL:000016984.14silver quality
temporal lobeUBERON:000187183.97gold quality
nucleus accumbensUBERON:000188283.62gold quality
Ammon’s hornUBERON:000195483.43gold quality
cerebellar vermisUBERON:000472082.93gold quality
neocortexUBERON:000195082.88gold quality
prefrontal cortexUBERON:000045182.65gold quality
caudate nucleusUBERON:000187382.60gold quality
dorsolateral prefrontal cortexUBERON:000983482.41gold quality
frontal cortexUBERON:000187082.38gold quality
substantia nigraUBERON:000203882.29gold quality
cerebral cortexUBERON:000095681.82gold quality
telencephalonUBERON:000189381.77gold quality
midbrainUBERON:000189181.47gold quality
Brodmann (1909) area 9UBERON:001354081.30gold quality
cartilage tissueUBERON:000241881.25gold quality
ganglionic eminenceUBERON:000402380.96gold quality
pancreatic ductal cellCL:000207980.56silver quality
putamenUBERON:000187480.55gold quality

Single-cell (SCXA)

Detected in 6 experiment(s), a significant marker in 5.

ExperimentMarker?Max mean expression
E-MTAB-9435yes583.31
E-MTAB-5061yes486.35
E-GEOD-84465yes236.69
E-GEOD-135922yes27.37
E-GEOD-137537yes8.06
E-ANND-3no1.54

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

34 targeting C1QL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-9-5P100.0072.282361
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-4510100.0066.602050
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-493-5P99.9672.472382
HSA-LET-7C-3P99.9573.422862
HSA-MIR-4731-5P99.8967.232537
HSA-LET-7A-2-3P99.8770.531921
HSA-MIR-449299.8768.253611
HSA-LET-7G-3P99.8570.431929
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-430799.8270.453374
HSA-MIR-132-3P99.7370.561424
HSA-MIR-212-3P99.7370.651424
HSA-MIR-10393-3P99.7266.56961
HSA-MIR-6801-5P99.7266.50981
HSA-MIR-6766-5P99.6867.702325
HSA-MIR-1249-5P99.6166.552049
HSA-MIR-6797-5P99.6166.552084
HSA-MIR-76299.5866.611994
HSA-MIR-449899.4767.422360
HSA-MIR-450599.2767.812678
HSA-MIR-133A-3P99.2771.531270
HSA-MIR-133B99.2771.531270
HSA-MIR-578799.2267.862628
HSA-MIR-5587-5P99.0768.58838
HSA-MIR-5001-5P99.0566.761972
HSA-MIR-1910-5P97.4266.36844

Literature-anchored findings (GeneRIF, showing 2)

  • Conserved recoding RNA editing of vertebrate C1q-related factor C1QL1. (PMID:19275900)
  • We conclude that the underexpression of CRABP1 and the overexpression of LCN2 may be useful diagnostic biomarkers in thyroid tumours with questionable malignity, and the overexpression of LCN2 and C1QL1 may be useful for prognostic purposes. (PMID:29321030)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioc1ql1ENSDARG00000043436
mus_musculusC1ql1ENSMUSG00000045532
rattus_norvegicusC1ql1ENSRNOG00000002963

Paralogs (23): C1QTNF3 (ENSG00000082196), COL19A1 (ENSG00000082293), PDCD7 (ENSG00000090470), COL10A1 (ENSG00000123500), C1QTNF6 (ENSG00000133466), C1QL2 (ENSG00000144119), COL8A1 (ENSG00000144810), C1QTNF2 (ENSG00000145861), C1QC (ENSG00000159189), C1QTNF7 (ENSG00000163145), C1QL3 (ENSG00000165985), COL8A2 (ENSG00000171812), C1QTNF4 (ENSG00000172247), C1QB (ENSG00000173369), C1QA (ENSG00000173372), C1QTNF1 (ENSG00000173918), ADIPOQ (ENSG00000181092), OTOL1 (ENSG00000182447), C1QTNF8 (ENSG00000184471), C1QL4 (ENSG00000186897), C1QTNF9B (ENSG00000205863), C1QTNF5 (ENSG00000223953), C1QTNF9 (ENSG00000240654)

Protein

Protein identifiers

C1q-related factorO75973 (reviewed: O75973)

Alternative names: C1q and tumor necrosis factor-related protein 14, Complement component 1 Q subcomponent-like 1

All UniProt accessions (1): O75973

UniProt curated annotations — full annotation on UniProt →

Function. May regulate the number of excitatory synapses that are formed on hippocampus neurons. Has no effect on inhibitory synapses.

Subunit / interactions. Interacts with ADGRB3. Forms heterooligomers with C1QL4, when proteins are coexpressed; this interaction does not occur after secretion.

Subcellular location. Secreted.

Tissue specificity. Expressed in brainstem.

RefSeq proteins (1): NP_006679* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001073C1q_domDomain
IPR008160CollagenRepeat
IPR008983Tumour_necrosis_fac-like_domHomologous_superfamily
IPR050822Cerebellin_Synaptic_OrgFamily

Pfam: PF00386, PF01391

UniProt features (7 total): domain 2, compositionally biased region 2, signal peptide 1, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75973-F179.260.52

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 136 (showing top): CREL_01, WANG_CLIM2_TARGETS_UP, BENPORATH_ES_WITH_H3K27ME3, GOBP_COGNITION, GOBP_BEHAVIOR, MCLACHLAN_DENTAL_CARIES_UP, PAX4_01, GOCC_COLLAGEN_TRIMER, GOBP_NEURON_MATURATION, GOBP_CELLULAR_COMPONENT_MAINTENANCE, GOBP_NEUROGENESIS, GGGTGGRR_PAX4_03, GOBP_CELL_CELL_SIGNALING, NFKB_Q6, GOBP_ANATOMICAL_STRUCTURE_MATURATION

GO Biological Process (5): locomotory behavior (GO:0007626), neuron remodeling (GO:0016322), motor learning (GO:0061743), maintenance of synapse structure (GO:0099558), regulation of synapse pruning (GO:1905806)

GO Molecular Function (2): signaling receptor binding (GO:0005102), protein binding (GO:0005515)

GO Cellular Component (7): collagen trimer (GO:0005581), cytoplasm (GO:0005737), synaptic cleft (GO:0043083), climbing fiber (GO:0044301), presynapse (GO:0098793), cerebellar climbing fiber to Purkinje cell synapse (GO:0150053), extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
behavior1
neuron maturation1
learning1
cell junction maintenance1
synapse organization1
regulation of synapse organization1
synapse pruning1
protein binding1
binding1
protein-containing complex1
intracellular anatomical structure1
extracellular region1
axon1
synapse1
asymmetric, glutamatergic, excitatory synapse1

Protein interactions and networks

STRING

1156 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C1QL1ADGRB3O60242798
C1QL1C1QTNF8P60827492
C1QL1C1QTNF1Q9BXJ1490
C1QL1C1QTNF9P0C862468
C1QL1COL25A1Q9BXS0449
C1QL1NBEAL1Q6ZS30447
C1QL1COL24A1Q17RW2445
C1QL1GLDNQ6ZMI3440
C1QL1COL9A1P20849439
C1QL1CTHRC1Q96CG8438
C1QL1C1RP00736428
C1QL1C1QL2Q7Z5L3422
C1QL1COL2A1P02458399
C1QL1COL15A1P39059394
C1QL1C1QL4Q86Z23388

IntAct

70 interactions, top by confidence:

ABTypeScore
C1QTNF9C1QTNF9Bpsi-mi:“MI:0914”(association)0.780
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
TMEM30BKLRG2psi-mi:“MI:0914”(association)0.530
DEFA5NUDT19psi-mi:“MI:0914”(association)0.530
COL10A1C1QL1psi-mi:“MI:0914”(association)0.530
CD1ESUSD5psi-mi:“MI:0914”(association)0.530
ZACNGPAA1psi-mi:“MI:0914”(association)0.530
YKT6C1QL1psi-mi:“MI:0914”(association)0.530
FUT3C1QL1psi-mi:“MI:0914”(association)0.530
TMED6SMPD2psi-mi:“MI:0914”(association)0.530
CBLN4C1QL1psi-mi:“MI:0914”(association)0.530
ADIPOQC1QL1psi-mi:“MI:0914”(association)0.530
LAIR2LAMA5psi-mi:“MI:0914”(association)0.530
C1QL1C1QTNF8psi-mi:“MI:0915”(physical association)0.400
C1QL1C1qtnf1psi-mi:“MI:0915”(physical association)0.400
C1QL1C1ql2psi-mi:“MI:0915”(physical association)0.400
C1qtnf9C1QL1psi-mi:“MI:0915”(physical association)0.400
TMED6UPK3BL1psi-mi:“MI:0914”(association)0.350
ICAM2NRP1psi-mi:“MI:0914”(association)0.350
HTR3AGPAA1psi-mi:“MI:0914”(association)0.350
MSRB3SPOPpsi-mi:“MI:0914”(association)0.350
CBLN4ADAM11psi-mi:“MI:0914”(association)0.350
F7C1QL1psi-mi:“MI:0914”(association)0.350

BioGRID (59): C1QL1 (Reconstituted Complex), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS)

ESM2 similar proteins: A5PKD9, B1AXV0, D1LYT2, D3Z7P3, D3ZB51, D3ZE85, D3ZTX0, E9PZ19, G3MWR8, O75973, O88508, O88992, O94925, P13264, P27467, P47870, P56704, P63137, Q00961, Q01098, Q08DW9, Q12841, Q14957, Q1LZ53, Q2LMP1, Q4R766, Q4W5Z4, Q4ZJM9, Q58D84, Q5R9Y1, Q5VWW1, Q5ZIN0, Q62356, Q62632, Q6AYT7, Q6AZB0, Q6UXG2, Q76LW2, Q7RTP6, Q7Z5L3

Diamond homologs: A0A060WQA3, A5PN28, A6NHN0, B2RNN3, O75973, O88992, P02745, P02746, P08125, P0C862, P14106, P14282, P23206, P25067, P25318, P27658, P31720, P31721, P83371, P98085, P98086, Q00780, Q02105, Q03692, Q05306, Q05A80, Q06575, Q06576, Q06577, Q0II24, Q15848, Q2KIU3, Q2KIX7, Q3Y5Z3, Q4ZJM7, Q4ZJM9, Q4ZJN1, Q5E9E3, Q5FVH0, Q5RJ80

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 80 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell711.7×4e-04

GO biological processes:

GO termPartnersFoldFDR
monoatomic ion transmembrane transport618.4×3e-04
adaptive immune response67.4×5e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

44 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance40
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1342375NC_000017.11:g.44846894_44962103delPathogenic

SpliceAI

414 predictions. Top by Δscore:

VariantEffectΔscore
17:44960363:CGCAC:Cacceptor_gain1.0000
17:44960364:GCAC:Gacceptor_gain1.0000
17:44960365:CAC:Cacceptor_gain1.0000
17:44960365:CACC:Cacceptor_gain1.0000
17:44960366:AC:Aacceptor_gain1.0000
17:44960367:CC:Cacceptor_gain1.0000
17:44960367:CCTG:Cacceptor_loss1.0000
17:44960368:CTGCG:Cacceptor_loss1.0000
17:44960369:T:Cacceptor_loss1.0000
17:44960374:G:GCacceptor_gain1.0000
17:44960382:C:CTacceptor_gain1.0000
17:44960385:G:Tacceptor_gain1.0000
17:44960368:C:CCacceptor_gain0.9900
17:44960372:G:Tacceptor_gain0.9900
17:44960374:G:Cacceptor_gain0.9900
17:44960384:C:CTacceptor_gain0.9900
17:44967482:A:ACdonor_gain0.9900
17:44967483:C:CCdonor_gain0.9900
17:44960365:CACCT:Cacceptor_gain0.9700
17:44967479:CATA:Cdonor_gain0.9700
17:44960364:GCACC:Gacceptor_gain0.9600
17:44960366:ACCTG:Aacceptor_gain0.9600
17:44960367:CCTGC:Cacceptor_gain0.9600
17:44967448:CCAC:Cdonor_loss0.9600
17:44967450:ACC:Adonor_loss0.9600
17:44967451:C:CTdonor_loss0.9600
17:44967452:C:Gdonor_loss0.9600
17:44967557:G:Adonor_gain0.9600
17:44960368:C:Aacceptor_gain0.9500
17:44960368:C:Tacceptor_gain0.9400

AlphaMissense

1677 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:44960206:G:CF253L1.000
17:44960206:G:TF253L1.000
17:44960208:A:GF253L1.000
17:44960210:C:TG252D1.000
17:44960211:C:GG252R1.000
17:44960214:A:GS251P1.000
17:44960216:A:GF250S1.000
17:44960221:G:CS248R1.000
17:44960221:G:TS248R1.000
17:44960223:T:GS248R1.000
17:44960225:T:CY247C1.000
17:44960226:A:GY247H1.000
17:44960243:C:TG241D1.000
17:44960247:G:CH240D1.000
17:44960264:A:GL234P1.000
17:44960276:A:TV230D1.000
17:44960294:A:GL224P1.000
17:44960300:A:GL222P1.000
17:44960308:G:CS219R1.000
17:44960308:G:TS219R1.000
17:44960310:T:GS219R1.000
17:44960311:G:CN218K1.000
17:44960311:G:TN218K1.000
17:44960314:G:CS217R1.000
17:44960314:G:TS217R1.000
17:44960316:T:GS217R1.000
17:44960318:G:TA216D1.000
17:44960324:T:AD214V1.000
17:44960342:T:AD208V1.000
17:44960342:T:GD208A1.000

dbSNP variants (sampled 300 via entrez): RS1000160920 (17:44967748 C>T), RS1000236506 (17:44960029 G>A,T), RS1000903668 (17:44961340 C>T), RS1001254748 (17:44959590 T>A), RS1001322378 (17:44969873 T>G), RS1001353090 (17:44969621 C>G,T), RS1001798767 (17:44969641 G>A,C), RS1001830093 (17:44969937 A>C), RS1001940071 (17:44962437 T>G), RS1002234374 (17:44965075 C>T), RS1002312119 (17:44962104 G>C), RS1002315011 (17:44966778 T>C,G), RS1002610014 (17:44965335 A>G), RS1002614243 (17:44965252 T>C), RS1002892738 (17:44962212 A>G,T)

Disease associations

OMIM: gene MIM:611586 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

9 associations (top):

StudyTraitp-value
GCST002058_13DNA methylation (variation)2.000000e-06
GCST003013_13White matter hyperintensity burden1.000000e-06
GCST003013_27White matter hyperintensity burden2.000000e-07
GCST004412_12Craniofacial microsomia9.000000e-06
GCST006585_2810Blood protein levels3.000000e-32
GCST007576_242Chronotype4.000000e-10
GCST008916_39Asthma8.000000e-12
GCST010703_91Brain morphology (MOSTest)2.000000e-65
GCST010922_12Hip bone mineral density and total body fat mass (bivariate analysis)5.000000e-09

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0022599DNA methylation
EFO:0005665white matter hyperintensity measurement
EFO:0008328chronotype measurement
EFO:0004346neuroimaging measurement
EFO:0007702hip bone mineral density

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression, increases methylation4
Benzo(a)pyreneaffects methylation, decreases methylation, increases expression, increases methylation3
sodium arsenitedecreases expression, increases abundance, increases expression2
Resveratrolaffects cotreatment, increases expression, decreases expression2
Copperincreases expression, affects cotreatment, affects binding2
Particulate Matterincreases abundance, decreases expression2
aristolochic acid Idecreases expression1
ethyl-p-hydroxybenzoatedecreases expression1
arseniteincreases methylation1
sulforaphanedecreases expression1
abrinedecreases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
NSC 689534increases expression1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicdecreases expression, increases abundance1
Atrazineincreases expression1
Chelating Agentsaffects binding, increases expression1
Cisplatindecreases expression1
Estradiolaffects cotreatment, decreases expression1
Leadaffects expression1
Plant Extractsaffects cotreatment, decreases expression1
Tretinoindecreases expression1
Cyclosporinedecreases expression1
Gold Compoundsdecreases methylation, increases expression1
Cadmium Chlorideincreases expression1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): craniofacial microsomia